Journal of women's health (2002)最新文献

{"title":"Female Permanent Contraception Procedures Surrounding the <i>Dobbs v. Jackson</i> Ruling at a Single Institution.","authors":"Bethlehem A Lulseged, Tori L Rockwell, Karen C Wang, Carolyn B Sufrin, Anne E Burke, Rebecca L Stone, Anja S Frost","doi":"10.1089/jwh.2024.0368","DOIUrl":"10.1089/jwh.2024.0368","url":null,"abstract":"<p><p><b><i>Introduction:</i></b> On June 24, 2022, the U.S. Supreme Court ruled against Jackson Women's Health Organization in <i>Dobbs v. Jackson</i> (2022), reversing the constitutional right to abortion. We aimed to describe the number of interval female permanent contraception procedures at a single institution surrounding the <i>Dobbs v. Jackson</i> ruling. <b><i>Methods:</i></b> We performed a retrospective chart review of permanent contraception procedures using relevant Current Procedural Terminology codes at one academic institution between June 2019 and May 2023. Contraception procedures across three, year-long preruling and one, year-long postruling periods were compared with one another; they were then also compared to percent changes in hysteroscopy procedures-a representation of average gynecological surgical volume. To reduce the impact of coronavirus, chi-square and difference-in-mean-proportions tests explored significance in the number of procedures during the 6/24/19-6/23/20 preruling and the 6/24/22-5/25/23 postruling period. <b><i>Results:</i></b> There were 913 contraception procedures performed: 611 in the preruling period and 302 in the postruling period. A 62.4% increase in procedures occurred between preruling period 1 (<i>n</i> = 186) and the postruling period (<i>n</i> = 302), and a 49.5% increase occurred between the 3-year preruling average (<i>n</i> = 202) and the postruling period. Relative to hysteroscopy procedures, there was a 44.6% and 39.3% increase in contraception procedures between preruling period 1 and the postruling period and the 3-year preruling average and the postruling period, respectively. A higher proportion of White and privately insured patients (<i>p</i> < 0.001, <i>p</i> < 0.001) underwent procedures postruling. <b><i>Conclusions:</i></b> Permanent contraception procedures increased following the <i>Dobbs</i> ruling, with differences found by race and insurance type. Further research is needed to explore the causes of increased procedures.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":"34 6","pages":"810-816"},"PeriodicalIF":0.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144278095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Evidence Is In: There Is Work to Be Done for Medical Student Parents.","authors":"Jessica L R De Haan","doi":"10.1089/jwh.2022.0237","DOIUrl":"https://doi.org/10.1089/jwh.2022.0237","url":null,"abstract":"","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"1375-1376"},"PeriodicalIF":3.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40540727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"<i>Correction to:</i> Addressing Racial Disparities in Pregnancy-Related Deaths: An Analysis of Maternal Mortality-Related Federal Legislation, 2017-2021 by Denise C. Carty et al. J Women's Health 2022;31(9):1222-1231; doi: 10.1089/jwh.2022.0336.","authors":"","doi":"10.1089/jwh.2022.0336.correx","DOIUrl":"https://doi.org/10.1089/jwh.2022.0336.correx","url":null,"abstract":"","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"1518"},"PeriodicalIF":3.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40666823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Care of Women During Menopause.","authors":"Lisa N Kransdorf,&nbsp;Julia A Files","doi":"10.1089/jwh.2022.0339","DOIUrl":"https://doi.org/10.1089/jwh.2022.0339","url":null,"abstract":"","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"1387-1390"},"PeriodicalIF":3.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33488004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of von Willebrand Disease on Women's Health Outcomes: A Matched Cohort Database Study.","authors":"Katrina Wilcox Hagberg,&nbsp;Susan Jick,&nbsp;Ping Du,&nbsp;Françoise Truong Berthoz,&nbsp;Gülden Özen,&nbsp;Spiros Tzivelekis","doi":"10.1089/jwh.2022.0082","DOIUrl":"https://doi.org/10.1089/jwh.2022.0082","url":null,"abstract":"<p><p><b><i>Objective:</i></b> To understand the impact of von Willebrand disease (VWD) on women's health, a retrospective cohort study was conducted using UK Clinical Practice Research Datalink (CPRD) GOLD database and Hospital Episode Statistics (HES) Admitted Patient Care data from 1988 to 2016. <b><i>Materials and Methods:</i></b> Hysterectomy and heavy menstrual bleeding (HMB) events were identified by recorded disease/clinical codes and compared in women with and without VWD (matched 1:10 by birth and CPRD record start years [±2 years], and general practice attended). Incidence rates and incidence rate ratios (IRR) were calculated; risks were estimated using the Kaplan-Meier method. <b><i>Results:</i></b> HMB was recorded after cohort entry in 388 of 1,335 women (29.1%) with VWD and 1,524 of 12,463 women (12.2%) without VWD. The cumulative incidence of HMB was higher in women with versus without VWD across all ages (<i>p</i> < 0.0001), and irrespective of prior HMB status (<i>p</i> < 0.001). Women with VWD were more likely to have HMB compared with women without VWD; IRR adjusted for age and prior HMB status was 2.74 (95% confidence interval [CI]: 2.44-3.07). Hysterectomy was recorded in 88 of 1,374 women (6.4%) with VWD and 320 of 12,791 women (2.5%) without VWD. The cumulative incidence of hysterectomy was higher for women with versus without VWD (<i>p</i> < 0.0001), and highest among women aged ≥30 years at cohort entry. Women with VWD aged 30 - 39 years were more likely to undergo hysterectomy than women without VWD; IRR adjusted for prior HMB was 3.58 (95% CI: 2.36 - 5.44). <b><i>Conclusions:</i></b> These findings highlight the substantial impact of VWD on women's health.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"1262-1270"},"PeriodicalIF":3.5,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40609295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Mental Health of Women with Gestational Diabetes During the COVID-19 Pandemic: An International Cross-Sectional Survey.","authors":"Claire A Wilson,&nbsp;Irene Gómez-Gómez,&nbsp;Judith Parsons,&nbsp;Raquel Costa,&nbsp;Ana Mesquita,&nbsp;Eleni Vousoura,&nbsp;Yolanda Contreras-García,&nbsp;Drorit Levy,&nbsp;Vera Mateus,&nbsp;Andri Christoforou,&nbsp;Ethel Felice,&nbsp;Pelin Dikmen-Yildiz,&nbsp;Sara Domínguez-Salas,&nbsp;Emma Motrico","doi":"10.1089/jwh.2021.0584","DOIUrl":"https://doi.org/10.1089/jwh.2021.0584","url":null,"abstract":"Introduction: There is evidence that women with gestational diabetes are at increased risk of the common mental disorders of anxiety and depression. The COVID-19 pandemic may have exerted an additional burden on the mental health of this population. The aim of this analysis was to compare levels of symptoms of common mental disorders and experiences during the COVID-19 pandemic between pregnant and postnatal women exposed and unexposed to gestational diabetes. Methods: Cross-sectional study utilizing quantitative data from an online survey administered across 10 countries to women who were pregnant or up to 6 months postpartum from 15 June to October 31, 2020. Women self-reported gestational diabetes and completed the Edinburgh Postnatal Depression Scale and GAD-7 (Generalized Anxiety Disorder 7 items) measures. The COPE-IS (Coronavirus Perinatal Experiences-Impact Survey) tool was also administered. Complete case analyses were conducted on a sample of 7,371 women. Results: There was evidence of an association between gestational diabetes and increased levels of depression symptoms, which was robust to adjustment for age, education, and employment status. There was only evidence of an association with anxiety in postnatal women. There was also evidence that women with gestational diabetes, particularly those in the postnatal period, experienced higher levels of pandemic-related distress, although they did not experience higher levels of COVID-19 infection in this sample. Conclusions: The increased risk of common mental disorders in women with gestational diabetes underscores the importance of integrated physical and mental health care for pregnant and postnatal women both during and beyond the pandemic. Clinical Trial Registration no. NCT04595123.","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"1232-1240"},"PeriodicalIF":3.5,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40619519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Fertility Benefits at Top U.S. Medical Schools.","authors":"Kim Hoang,&nbsp;Neal Evans,&nbsp;Lusine Aghajanova,&nbsp;Hina Talib,&nbsp;Eleni Linos,&nbsp;Jessica M Gold","doi":"10.1089/jwh.2021.0486","DOIUrl":"https://doi.org/10.1089/jwh.2021.0486","url":null,"abstract":"<p><p><b><i>Background:</i></b> Female physicians have a higher prevalence of infertility compared with the general population. Physician well-being can be significantly impacted by the physical and emotional challenges associated with this, including the high cost of fertility treatments, which are often not covered by health insurance. There are limited data on the current state of fertility coverage available for physicians. This study examines fertility insurance benefits offered for faculty at top U.S. medical schools. <b><i>Methods:</i></b> Between March and April 2021, we reviewed fertility benefits at medical schools ranked in the top 14 for research as identified by the <i>US News & World Report 2021</i>. The summary plan descriptions of benefits were collected from each institution's human resources (HR) website and direct phone call to HR representatives. We examined descriptions of coverage for fertility services including evaluation, treatments, medications, maximum lifetime coverage, and whether a formal diagnosis of infertility was required for benefit eligibility. <b><i>Results:</i></b> Fourteen institutions offer benefits for fertility evaluation and 13 offer benefits for treatment. Of the 13 institutions that offer treatment coverage, 11 cover <i>in vitro</i> fertilization, with 6 having limits on the number of cycles. Twelve offer medication coverage. Ten institutions specified maximum lifetime coverage for treatments and medications, ranging from $10,000 to $100,000. Only 1 school provided coverage for elective fertility preservation, and none covered surrogacy expenses. Half of the schools are in states where fertility benefits are mandated. <b><i>Conclusion:</i></b> There is wide variation in fertility benefits offered at top medical schools across the country. Many schools offered coverage for fertility evaluation and treatments; however, majority had restrictions and limitations to the benefits, suggesting that there is still inadequate coverage provided. This study's selected sample also does not reflect other medical schools across the country, which may not be as well-resourced in their provision of fertility benefits.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"1369-1373"},"PeriodicalIF":3.5,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39919862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Associations of Infant Feeding with Body Composition and Cardiometabolic Health in Young Female University Students.","authors":"Mari Honda,&nbsp;Ayaka Tsuboi,&nbsp;Satomi Minato-Inokawa,&nbsp;Mika Takeuchi,&nbsp;Miki Kurata,&nbsp;Tomofumi Takayoshi,&nbsp;Yushi Hirota,&nbsp;Bin Wu,&nbsp;Tsutomu Kazumi,&nbsp;Keisuke Fukuo","doi":"10.1089/jwh.2021.0464","DOIUrl":"https://doi.org/10.1089/jwh.2021.0464","url":null,"abstract":"<p><p><b><i>Background:</i></b> We assessed the association of infant feeding with body composition and cardiometabolic health at 20 years in a setting where infant feeding is not associated with socioeconomic status. <b><i>Materials and methods:</i></b> Body size trajectory since birth, current body composition measured using whole-body dual-energy X-ray absorptiometry, and a broad range of cardiometabolic risk factors were compared cross-sectionally among young female university students who were ever breastfed (<i>n</i> = 158, 120 exclusively, and 38 mainly), mixed fed (<i>n</i> = 124), and formula fed (<i>n</i> = 15, 10 mainly, and 5 exclusively) <b><i>Results:</i></b> Compared with breastfed and mixed fed women, formula fed women had higher serum total and low-density lipoprotein (LDL) cholesterol although fat mass, fat distribution, fasting glucose, and insulin and high-density lipoprotein cholesterol did not differ. In addition, resting heart rates were higher in formula fed women compared with the other two groups of women although systolic and diastolic blood pressure did not differ. Further, formula fed women had higher adiponectin while serum leptin did not differ. There was no difference in birthweight, weight and height in childhood and adolescence, and glucose tolerance. On multivariate logistic regression analysis, formula feeding was associated with resting heart rates (odds ratio [OR]: 1.06, confidence interval [95% CI]; 1.01-1.12, <i>p</i> = 0.01) and adiponectin (OR: 1.3, 95% CI; 1.1-1.5, <i>p</i> < 0.001) independently of serum total and LDL cholesterol. <b><i>Conclusions:</i></b> Breastfeeding may be associated with favorable lipid profile and autonomic nervous function in young adults through mechanisms unrelated to adiposity, implicating potential long-term benefits of breastfeeding for cardiovascular health. Higher adiponectin in nonbreastfed women warrants further studies.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"1358-1363"},"PeriodicalIF":3.5,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39797174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preconception Health and Disability Status Among Women of Reproductive Age Participating in the National Health and Nutrition Examination Surveys, 2013-2018.","authors":"Andrea L Deierlein,&nbsp;Jaqueline Litvak,&nbsp;Cheryl R Stein","doi":"10.1089/jwh.2021.0420","DOIUrl":"https://doi.org/10.1089/jwh.2021.0420","url":null,"abstract":"<p><p><b><i>Background:</i></b> Preconception health is a critical determinant of health outcomes for women and their offspring. Given higher rates of prenatal and postpartum complications among women with disabilities, it is important to investigate a range of preconception health indicators in this population. <b><i>Materials and Methods:</i></b> Data were from women of reproductive age (18-44 years) who participated in the National Health and Nutrition Examination Surveys, 2013-2018. Disability was self-reported as serious difficulty hearing, seeing, concentrating, walking, dressing, and/or running errands due to physical, mental, or emotional conditions. Preconception health indicators were adapted from those developed by the Core State Preconception Health Indicators Working Group. Multivariable Poisson regression estimated adjusted prevalence ratios (aPRs) and 95% confidence intervals of preconception health indicators among women with disabilities compared with those without disabilities. <b><i>Results:</i></b> Of 4055 women, 601 (15%, weighted) reported having any disabilities, and of these women, 220 (6%) reported having 2 or more types of disabilities. Women with any disabilities were more likely to have suboptimal preconception health indicators compared with women without disabilities, including low education and household income, no recent dental visit, difficulty getting pregnant, current smoking, binge drinking, drug use, obesity, no multivitamin use, physical inactivity, long sleep durations, asthma, hypertension, and sexually transmitted infections (aPRs from 1.1 to 2.0). The greatest disparities between women with and without disabilities were for indicators of self-rated poor or fair general health, depression, and diabetes, with aPRs ranging from 2.4 to 3.8. <b><i>Conclusions:</i></b> Disparities in preconception health indicators are modifiable and may be addressed through adequate access to health care, interventions targeting lifestyle and health behaviors, and education and training for all health practitioners.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"1320-1333"},"PeriodicalIF":3.5,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39919865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"In Defense of Mothers: Why Pregnant and Breastfeeding Women Should Be Included in Mass Drug Administration Programs.","authors":"Megan G Lord","doi":"10.1089/jwh.2022.0267","DOIUrl":"https://doi.org/10.1089/jwh.2022.0267","url":null,"abstract":"<p><p>Mass drug administration (MDA) programs are a critical component of efforts to treat and eliminate trachoma, a leading cause of blindness worldwide. Despite the importance of these programs for individual and community health, pregnant and breastfeeding women have historically been excluded from treatment in these programs. Countries with active MDA programs also tend to have high fertility rates, and thus women may be left untreated for years at a time. Not only do these women suffer from the symptoms of disease (pain and eventual blindness), but also failure to include the entire population in drug administration programs leaves pockets of infection in the community, risking outright failure of eradication efforts. The medication used most commonly, azithromycin, appears to be safe for use in pregnancy and breastfeeding. The time has come to include pregnant and breastfeeding women in MDA programs, not just for them, but also for their communities.</p>","PeriodicalId":520699,"journal":{"name":"Journal of women's health (2002)","volume":" ","pages":"1219-1221"},"PeriodicalIF":3.5,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40597727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}